Lee T. Bacheler

4.9k citations

82 papers · 3.8k indexed · 1 hit paper · h-index 31

Co-authors: Susan Erickson‐Viitanen Ronald M. Klabe Beverly C. Cordova Chong‐Hwan Chang Marlene M. Rayner Prabhakar K. Jadhav Michaël Otto James L. Meek
Topics: HIV Research and Treatment (67 papers)HIV/AIDS drug development and treatment (67 papers)HIV/AIDS Research and Interventions (26 papers)
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: Science Cell Proceedings of the National Academy of Sciences
Partner nations: United States United Kingdom Canada

In The Last Decade

Lee T. Bacheler

81 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors

1994 680 citations Patrick Y. S. Lam, Prabhakar K. Jadhav et al. profile →

Peers

Countries citing papers authored by Lee T. Bacheler

Since Specialization

Citations

This map shows the geographic impact of Lee T. Bacheler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee T. Bacheler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee T. Bacheler more than expected).

Fields of papers citing papers by Lee T. Bacheler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee T. Bacheler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee T. Bacheler. The network helps show where Lee T. Bacheler may publish in the future.

Co-authorship network of co-authors of Lee T. Bacheler

This figure shows the co-authorship network connecting the top 25 collaborators of Lee T. Bacheler. A scholar is included among the top collaborators of Lee T. Bacheler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee T. Bacheler. Lee T. Bacheler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The non-nucleoside reverse transcriptase inhibitor efavirenz stimulates replication of human immunodeficiency virus type 1 harboring certain non-nucleoside resistance mutations 2010 ·Virology ·(unknown),Hua Liang,Lee T. Bacheler,Hao Wu,(unknown),Lisa M. Demeter,Carrie Dykes	12
2	A comparison of HIV‐1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype 2009 ·Journal of Medical Virology ·Margriet Van Houtte,Gastón Picchio,Koen Van der Borght,Theresa Pattery,Pierre Lecocq,Lee T. Bacheler	25
3	Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals 2009 ·Journal of Clinical Virology ·Prakash Sista,Alex R. Rinehart,(unknown),(unknown),Theresa Pattery,Lee T. Bacheler	8
4	A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients 2009 ·AIDS ·Lisa M. Demeter,Hongyu Jiang,Aprateem Mukherjee,Gene D. Morse,Robin DiFrancesco,Robert DiCenzo,Carrie Dykes,Prakash Sista,Lee T. Bacheler,Karin L. Klingman,Alex R. Rinehart,Mary Albrecht	14
5	A 21-Base Pair Insertion/Duplication at Codon 69 of the HIV Type 1 Reverse Transcriptase in a Patient Undergoing Multiple Nucleoside Therapy 2007 ·AIDS Research and Human Retroviruses ·P. Richard Harrigan,Theresa Mo,(unknown),Zabrina L. Brumme,Paula McKenna,Lee T. Bacheler	4
6	NRTI resistance associated with the RT mutation K70E in HIV-1 2006 ·Antiviral Therapy ·Margriet Van Houtte,(unknown),Anna María Geretti,Theresa Pattery,Lee T. Bacheler	3
7	Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G (vol 20, pg 1789, 2006) 2006 ·Ana Abecasis,Koen Deforche,Joke Snoeck,Lee T. Bacheler,Paula McKenna,A.P. Carvalho,Perpétua Gómes,Ricardo Camacho,Anne–Mieke Vandamme	1
8	Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors 2005 ·AIDS ·P. Richard Harrigan,Theresa Mo,Brian Wynhoven,(unknown),Zabrina L. Brumme,Paula McKenna,Theresa Pattery,Johan Vingerhoets,Lee T. Bacheler	34
9	Application of multiple linear regression modelling to the quantitative prediction of HIV-1 drug susceptibility phenotype from viral genotype 2004 ·Antiviral Therapy ·Hans Vermeiren,Tim Van den Bulcke,Herwig Van Marck,Pierre Lecocq,Margriet Van Houtte,Lee T. Bacheler	2
10	Characterization of Mutations in CRF01_AE Virus Isolates From Antiretroviral Treatment-Naive and -Experienced Patients in Singapore 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Li Yang Hsu,(unknown),Lee T. Bacheler,Nicholas I. Paton	28
11	Quantitative prediction of HIV drug susceptibility from viral genotype through linear regression modelling 2003 ·Antiviral Therapy ·Herwig Van Marck,Tim Van den Bulcke,Margriet Van Houtte,Pierre Lecocq,Lee T. Bacheler	2
12	Synthesis and Evaluation of Efavirenz (SustivaTM) Analogues as HIV-1 Reverse Transcriptase Inhibitors: Replacement of the Cyclopropylacetylene Side Chain 2001 ·Bioorganic & Medicinal Chemistry Letters ·Anthony J. Cocuzza,Dennis R. Chidester,Beverly C. Cordova,Susan Jeffrey,Rodney L. Parsons,Lee T. Bacheler,Susan Erickson‐Viitanen,George L. Trainor,(unknown)	67
13	Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert J. McHugh,Beverly C. Cordova,Ronald M. Klabe,Lee T. Bacheler,Susan Erickson‐Viitanen,James D. Rodgers	81
14	Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors 1998 ·Chemistry & Biology ·James D. Rodgers,Patrick Y. S. Lam,Barry L. Johnson,Haisheng Wang,Soo S. Ko,Steven P. Seitz,George L. Trainor,Paul Anderson,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Sena Garber,Carol Reid,Matthew Wright,Chong‐Hwan Chang,Susan Erickson‐Viitanen	1
15	The synthesis of symmetrical and unsymmetrical P1/P1′ cyclic ureas as HIV protease inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert F. Kaltenbach,David A. Nugiel,Robert J. McHugh,Prabhakar K. Jadhav,Lee T. Bacheler,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,Sena Garber,Carol Reid,Steven P. Seitz	19
16	Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2′ groups 1998 ·Bioorganic & Medicinal Chemistry Letters ·James D. Rodgers,Barry L. Johnson,(unknown),Susan Erickson‐Viitanen,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Chong‐Hwan Chang	34
17	The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: Modifications of the P1/P1′ residues 1998 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Lee T. Bacheler,Marlene M. Rayner,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,Steven P. Seitz	16
18	Construction of Infectious Molecular Clones of HIV-1 Containing Defined Mutations in the Protease Gene 1994 ·Biochemical and Biophysical Research Communications ·Dean L. Winslow,Elizabeth D. Anton,Robert A. Horlick,Robert J. Zagursky,R.J. Tritch,Helen Scarnati,Kate G. Ackerman,Lee T. Bacheler	11
19	Human Chromosome-Dependent and -Independent Pathways for HIV-2 Trans-Activation 1991 ·AIDS Research and Human Retroviruses ·Clyde E. Hart,(unknown),J C Galphin,Chin‐Yih Ou,Lee T. Bacheler,(unknown),John J. Wasmuth,Irvin S. Y. Chen,Gerald Schochetman	8
20	HIV-1 Neutralizing Monoclonal Antibodies Induced by a Synthetic Peptide 1990 ·AIDS Research and Human Retroviruses ·Paul J. Durda,Lee T. Bacheler,Paul R. Clapham,(unknown),Barbara A. Leece,Thomas J. Matthews,Áine McKnight,Roger J. Pomerantz,Marlene M. Rayner,Kent J. Weinhold	40

About Lee T. Bacheler

Lee T. Bacheler is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 82 papers that have together received 3.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (67 papers), HIV/AIDS drug development and treatment (67 papers) and HIV/AIDS Research and Interventions (26 papers). The work is most often cited by research in Virology (2.1k citations), Infectious Diseases (2.1k citations) and Organic Chemistry (1.0k citations). Lee T. Bacheler has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Susan Erickson‐Viitanen, Ronald M. Klabe, Beverly C. Cordova, Chong‐Hwan Chang, Marlene M. Rayner, Prabhakar K. Jadhav, Michaël Otto, James L. Meek, H Fan and Sena Garber. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact